| HIV/AIDS - Breakthrough discovery in HIV research opens path to new, better therapies |
|
|
|
|
| |
|
| |
The latest HIV/AIDS news from News Medical |
|
|
|
 | | |  Understanding HIV’s resistance to Antiretrovirals As of 2018, 37.9 million people worldwide are known to be living with HIV. This is a major epidemic with 1.7 million new infections in 2018 alone. These high rates of infection provide a large gene pool from which resistant strains can emerge. Although there are two variants of HIV which have overcome the species barrier, the HIV-1 variant is more virulent and widespread and therefore is the variant that will be discussed. | |
|
|
|
|
| | |  Though many negative repercussions of human immunodeficiency virus infection can be mitigated with the use of antiretroviral therapy, one area where medical advances haven't made as much progress is in the reduction of cognitive impacts. | | | | |  People living with HIV/AIDS are at increased risk of depressive disorders. But all too often, these conditions go unrecognized or untreated, suggests a literature review in the May/June issue of Harvard Review of Psychiatry. | | | | |  Some people with HIV need to undergo an allogeneic stem cell transplantation in order to treat different types of blood cancer. Most of the patient's immune cells are eliminated during these transplantations. | | | | |  A new qualitative study by researchers at Columbia University Mailman School of Public Health found that the majority of women living with HIV would endorse a monthly long acting injectable (LAI) antiretroviral therapy over current daily pills. | |
|
|
|
|
|
